The invention relates to the use of (R)–2–{(S)6,7-dimethoxy–1-[2–(4-trifluoromethylphenyl)ethyl]-3,4-dihydro-1H-isoquinilin-2-yl} N-methyl-2-phenylacetamide for the preparation of a medicament to enhance, maintain and/or restore all stages and/or types of short-, middle- and/or long-term memory.
TETRAHYDROISOQUINOLINE DERIVATIVES TO ENHANCE MEMORY FUNCTION